financetom
Business
financetom
/
Business
/
EverQuote Positioned For Growth As Auto Carriers Boost Customer Acquisition, Analyst Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
EverQuote Positioned For Growth As Auto Carriers Boost Customer Acquisition, Analyst Says
Feb 25, 2025 9:53 AM

EverQuote, Inc. ( EVER ) shares are trading higher on Tuesday. On Monday, the company reported fourth-quarter results and issued first-quarter revenue guidance above estimates.

The company reported EPS of $0.33, missing the $0.39 estimate, while sales of $147.46 million exceeded the $133.86 million estimate.

EverQuote ( EVER ) expects first-quarter FY25 sales of $155 million-$160 million vs. consensus of $136.86 million and adjusted EBITDA of $19 million-$21 million.

JPMorgan analyst Cory A. Carpenter raised the price forecast from $25 to $29 and reiterated an Overweight rating, reflecting upward estimate revisions and the removal of the 1×1 consent overhang.

The analyst said the company has continued the trend of exceeding expectations, with revenue surpassing the upper end of guidance by 8%, driven by auto carriers increasing customer acquisition spending late in the quarter.

EverQuote’s first-quarter guidance was 15% higher than Street estimates, partly due to fewer challenges from the vacated 1×1 consent rule, added the analyst.

Carpenter wrote that while revenue growth was expected to normalize around 15%-20% through the year, he saw the potential for further upside as several carriers remained inactive and some states were still largely closed.

Also, Needham analyst Mayank Tandon maintained a Buy rating and raised the price forecast from $30 to $38.

Investors can gain exposure to the stock via Inspire Fidelis Multi Factor ETF ( FDLS ) .

EVER Price Action: EverQuote ( EVER ) shares are up 18.71 % at $23.92 at publication Tuesday.

Read Next:

Dan Loeb Adjusts Healthcare Holdings: Danaher Stake Trimmed As Thermo Fisher Gains Favor

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Medpace Holdings Insider Sold Shares Worth $15,924,222, According to a Recent SEC Filing
Medpace Holdings Insider Sold Shares Worth $15,924,222, According to a Recent SEC Filing
May 17, 2024
04:17 PM EDT, 05/17/2024 (MT Newswires) -- August J. Troendle, 10% Owner, Director, CEO, on May 15, 2024, sold 39,342 shares in Medpace Holdings ( MEDP ) for $15,924,222. Following the Form 4 filing with the SEC, Troendle has control over a total of 5,401,432 shares of the company, with 668,413 shares held directly and 4,733,019 controlled indirectly. SEC Filing:...
Vital Farms Insider Sold Shares Worth $551,992, According to a Recent SEC Filing
Vital Farms Insider Sold Shares Worth $551,992, According to a Recent SEC Filing
May 17, 2024
04:22 PM EDT, 05/17/2024 (MT Newswires) -- Karl Khoury, Director, on May 15, 2024, sold 15,000 shares in Vital Farms ( VITL ) for $551,992. Following the Form 4 filing with the SEC, Khoury has control over a total of 140,069 shares of the company, with 140,069 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1579733/000141588924013492/xslF345X03/form4-05172024_040547.xml Price: 37.42, Change: -0.22, Percent Change: -0.58...
Home Depot Insider Sold Shares Worth $1,031,370, According to a Recent SEC Filing
Home Depot Insider Sold Shares Worth $1,031,370, According to a Recent SEC Filing
May 17, 2024
04:23 PM EDT, 05/17/2024 (MT Newswires) -- Fahim Siddiqui, Executive Vice President and Chief Information Officer, on May 16, 2024, sold 3,000 shares in Home Depot ( HD ) for $1,031,370. Following the Form 4 filing with the SEC, Siddiqui has control over a total of 8,155 shares of the company, with 8,155 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/354950/000035495024000137/xslF345X03/wk-form4_1715976939.xml ...
Regeneron Pharmaceuticals Insider Sold Shares Worth $48,636,545, According to a Recent SEC Filing
Regeneron Pharmaceuticals Insider Sold Shares Worth $48,636,545, According to a Recent SEC Filing
May 17, 2024
04:14 PM EDT, 05/17/2024 (MT Newswires) -- George Yancopoulos, Director, Board Co-Chair, President & Chief Scientific Officer, on May 16, 2024, sold 50,000 shares in Regeneron Pharmaceuticals ( REGN ) for $48,636,545. Following the Form 4 filing with the SEC, Yancopoulos has control over a total of 1,148,844 shares of the company, with 786,383 shares held directly and 362,461 controlled...
Copyright 2023-2026 - www.financetom.com All Rights Reserved